What qualifies someone else for GLP-1 meds may not necessarily qualify you
Clinical trials demonstrate approximately 17.8% weight loss at the 15mg dose over 68-72 weeks
- Retatrutide is studied as a multi-receptor peptide in controlled research environments where investigators are evaluating the interaction between GLP-1 receptor signaling, GIP receptor activity, glucagon receptor pathways, metabolic adaptation, insulinotropic pathway behavior, appetite-associated signaling models, and energy expenditure biology
Even at lower doses, GLP-1s are prescription medications that affect multiple organ systems. So while accessing these medications may feel as simple as clicking a button, its worth pausing before you hit add to cart. Doing a little legwork upfront ensures youre choosing a platform thats actually safe, reputable, and equipped to support a microdosed approachnot just sell you something
First, it is difficult for GLP-1 agonists to achieve anti-fibrosis effects because the major effect of GLP-1 agonists on MASH is likely to be indirect by extrahepatic path
But how do they really work inside the body